BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3373261)

  • 1. Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma.
    Saleh MN; Miller DM; Peterson L; Russell CD; Unger MW; Urist MM; Wheeler RH; LoBuglio AF
    J Clin Oncol; 1988 Jun; 6(6):1059-65. PubMed ID: 3373261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
    Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
    Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.
    Carrasquillo JA; Abrams PG; Schroff RW; Reynolds JC; Woodhouse CS; Morgan AC; Keenan AM; Foon KA; Perentesis P; Marshall S
    J Nucl Med; 1988 Jan; 29(1):39-47. PubMed ID: 3335926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
    Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
    J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
    Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
    Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibodies.
    Taylor A; Milton W; Eyre H; Wu FP; Christian P; Alazraki N; Datz F; Unger MW
    NCI Monogr; 1987; (3):25-31. PubMed ID: 3821915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
    Larson SM
    Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
    Scott AM; Lee FT; Hopkins W; Cebon JS; Wheatley JM; Liu Z; Smyth FE; Murone C; Sturrock S; MacGregor D; Hanai N; Inoue K; Yamasaki M; Brechbiel MW; Davis ID; Murphy R; Hannah A; Lim-Joon M; Chan T; Chong G; Ritter G; Hoffman EW; Burgess AW; Old LJ
    J Clin Oncol; 2001 Oct; 19(19):3976-87. PubMed ID: 11579119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
    Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
    J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapatient and interpatient comparison of tumor size and monoclonal antibody uptake in melanoma.
    Cornelius EA; Neumann RD; Zoghbi SS; Kirkwood JM; Ernstoff MS; Unger MM
    Clin Nucl Med; 1988 Apr; 13(4):243-9. PubMed ID: 3370893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
    Frontiera M; Murray JL; Lamki L; Thomas J; Satterlee W; Schmelter R; Rosenblum MG; Khazaeli MB; Unger MW; Robinson WA
    Clin Nucl Med; 1989 May; 14(5):357-66. PubMed ID: 2656042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor immunoscintigraphy by means of radiolabeled monoclonal antibodies: multicenter studies of the Italian National Research Council--Special Project "Biomedical Engineering".
    Siccardi AG
    Cancer Res; 1990 Feb; 50(3 Suppl):899s-903s. PubMed ID: 2404584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor localization by tumor infiltrating lymphocytes labeled with indium-111 in patients with metastatic renal cell carcinoma, melanoma, and colorectal cancer.
    Dillman RO; Hurwitz SR; Schiltz PM; Barth NM; Beutel LD; Nayak SK; O'Connor AA
    Cancer Biother Radiopharm; 1997 Apr; 12(2):65-71. PubMed ID: 10851449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of melanoma with L-131-labeled monoclonal antibodies.
    Larson SM; Brown JP; Wright PW; Carrasquillo JA; Hellström I; Hellström KE
    J Nucl Med; 1983 Feb; 24(2):123-9. PubMed ID: 6822875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m labeled monoclonal antibodies in the detection of metastatic melanoma.
    Serafini AN; Kotler J; Feun L; Dewanjee M; Robinson D; Salk D; Sfakianakis G; Abrams P; Savaraj N; Goodwin D
    Clin Nucl Med; 1989 Aug; 14(8):580-7. PubMed ID: 2805539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of malignant melanoma using monoclonal antibodies.
    Wasselle J; Becker J; Cruse W; Espinosa C; Cox C; Reintgen D
    Arch Surg; 1991 Apr; 126(4):481-4. PubMed ID: 2009063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
    Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
    J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
    Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
    Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.